Home / Business and Economy / Insider Sells BillionToOne Stock
Insider Sells BillionToOne Stock
13 Jul
Summary
- An insider sold 801 BillionToOne shares on July 1, 2026.
- The sale occurred under a Rule 10b5-1 trading plan.
- BillionToOne has a $5.5 billion market cap and $354.5M revenue.
Nancy Joann Johnson sold 801 shares of BillionToOne, Inc. on July 1, 2026. This trade was conducted using a Rule 10b5-1 plan established on March 6, 2026. This plan allows company insiders to execute trades based on a predetermined schedule, thereby addressing concerns related to material non-public information.
Following this transaction, the insider's direct ownership in BillionToOne now stands at 21,099 shares of Class A Common Stock. As of July 2, 2026, BillionToOne holds a market capitalization of $5.5 billion. The company reported trailing twelve months revenue of $354.5 million and a net income of $25.2 million.
BillionToOne specializes in molecular diagnostics, utilizing a proprietary molecular counting platform. This technology powers products like UNITY Complete, a non-invasive prenatal screening test that assesses fetal risk for chromosomal abnormalities. The company serves the obstetric and reproductive health markets.
